What is Paxil?
Paxil is a potent selective serotonin reuptake inhibitor and has been successful at helping thousands of individuals throughout the United States who suffer from severe mental health disorders. It has also been used to treat chronic headaches, diabetic side-effects, premenstrual dysphoric disorder, and bipolar disorder. Paxil was approved for use in the United States in 1992. Marketed and sold by SmithKline Beecham, a British pharmaceuticals company that is now GlaxoSmithKline (GSK), it rose in popularity through the 2000s to become the fifth-most prescribed antidepressant in the U.S. At its height in 2007, experts estimate doctors were writing more than 18 million prescriptions for this medication. In 2004, the FDA investigated the drug and released a new warning. According to the FDA, Paxil can increase the risk for suicidal tendencies if taken by young adults 18 to 24 years of age. Shortly after the FDA warning, GlaxoSmithKline (GSK) modified their marketing and warning labels to warn users of the increased risk to young users. Over the years, GlaxoSmithKline (GSK) has experienced a variety of legal issues. They have been accused of promoting Paxil to children, failing to label Paxil correctly, stalling the sale of the generic medication, and withholding safety information.